Sinopharm Tech Holdings Limited reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was HKD 10.05 million compared to HKD 9.15 million a year ago. Net loss was HKD 4.11 million compared to HKD 9.51 million a year ago. Basic loss per share from continuing operations was HKD 0.0009 compared to HKD 0.0022 a year ago.
For the six months, sales was HKD 11.73 million compared to HKD 55.2 million a year ago. Net loss was HKD 13.5 million compared to HKD 14.14 million a year ago. Basic loss per share from continuing operations was HKD 0.003 compared to HKD 0.0033 a year ago.